Truist Financial Increases CVS Health (NYSE:CVS) Price Target to $82.00
CVS Health (NYSE:CVS – Free Report) had its price target increased by Truist Financial from $76.00 to $82.00 in a research report report published on Friday,Benzinga reports. Truist Financial currently has a buy rating on the pharmacy operator’s stock. Several other equities research analysts have also recently issued reports on CVS. Piper Sandler boosted their […]
More Stories
Stifel Nicolaus Cuts Meta Platforms (NASDAQ:META) Price Target to $628.00
Meta Platforms (NASDAQ:META – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from...
Needham & Company LLC Reiterates “Underperform” Rating for Meta Platforms (NASDAQ:META)
Meta Platforms (NASDAQ:META – Get Free Report)‘s stock had its “underperform” rating restated by investment analysts at Needham & Company...
Raymond James Financial Inc. Takes Position in Monarch Casino & Resort, Inc. (NASDAQ:MCRI)
Raymond James Financial Inc. acquired a new stake in shares of Monarch Casino & Resort, Inc. (NASDAQ:MCRI – Free Report)...
Critical Review: NET Power (NPWR) & The Competition
NET Power (NYSE:NPWR – Get Free Report) is one of 21 public companies in the “Electrical industrial apparatus” industry, but...
Raymond James Financial Inc. Invests $5.94 Million in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS)
Raymond James Financial Inc. acquired a new stake in John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS – Free Report) during...
H&E Equipment Services, Inc. (NASDAQ:HEES) Shares Sold by Legal & General Group Plc
Legal & General Group Plc trimmed its position in shares of H&E Equipment Services, Inc. (NASDAQ:HEES – Free Report) by...